Research Square (Research Square),
Год журнала:
2022,
Номер
unknown
Опубликована: Май 25, 2022
Abstract
Background:
Deprescribing
as
the
part
of
optimal
health
care
is
aimed
at
reducing
overall
impact
polypharmacy
on
patients
and
services.
Understanding
how
older
adults
their
caregivers
understand
deprescribing
crucial
to
ensuring
a
holistic
approach
deprescribing.
Objective:
To
assess
attitude
towards
medication
Ambo
university
referral
hospital.
Methodology:
Institutional
based
cross-sectional
study
was
conducted
using
revised
Patient
Attitude
Towards
tool
(rPATD).
The
collected
data
were
processed
analyzed
by
statistical
package
for
social
science
(SPSS-25)
presented
in
tables.
Backward
linear
regression
logistic
used
determine
degree
association
between
dependent
independent
variables.
95%
confidence
interval
two
sides
P-value
≤
0.05
utilized
reporting.
Result:
One
hundred
fifty
six
(81.3%)
respondents
(i.e.85%
77.2%
caregivers)
agreed
stop
one
or
more
regular
medications
if
physician
recommends
doing
so
despite
98(51.0%)
them
(i.e.
49%
53.3%
being
satisfied
with
their/their
recipient’s
medications.
On
aggregate
mean
score,
had
neutral
position
(2.6-3.59)
regarding
burden
concerns
stopping
factor
score
whereas
majority
disagree
(1-2.59)
inappropriateness
they
been
received
(3.6-5)
need
involvement
medicine
decision
making.
Concerns
scores
(AOR=0.440,
CI=0.262-0.741,
P=0.035)
significantly
associated
willingness
have
medicine(s)
deprescribed.
Perceived
levels
(AOR=0.653,
CI=
0.456-0.936,
P=0.020)
satisfaction
medicines
regimen.
Conclusion:
Majority
would
be
willing
stopped
physicians
recommend
it.
Having
higher
perceived
main
determinants
deprescribe
respectively.
Healthcare
providers
should
prompt
process
clinical
practice.
JAMA Network Open,
Год журнала:
2025,
Номер
8(2), С. e2457498 - e2457498
Опубликована: Фев. 10, 2025
Importance
Better
understanding
of
patients’
attitudes
toward
deprescribing
specific
medications
will
inform
future
interventions.
Objective
To
investigate
older
adults’
by
investigating
which
they
would
like
to
have
deprescribed,
the
reasons
why,
and
patient
factors
associated
with
interest
in
deprescribing.
Design,
Setting,
Participants
This
survey
study
was
conducted
from
May
2022
December
2023
primary
care
settings
14
countries.
Patients
aged
65
years
or
taking
5
more
were
consecutively
recruited
their
general
practitioner
(GP)
completed
questionnaire.
Exposures
Patient
characteristics,
including
gender,
number
medications,
GP
education
level,
financial
status,
confidence
completing
medical
forms,
self-rated
health,
satisfaction
trust
GP,
country.
Main
Outcomes
Measures
The
outcomes
as
measured
responses
question,
“Thinking
about
your
current
medication
list,
are
there
any
that
you
stop
reduce
dose
of?”
Multilevel
multivariable
logistic
regression
analysis
used,
adjusted
for
clustering
effect
at
country
association
between
characteristics
Results
Of
1340
patients
(mean
[SD],
96
[47]
per
country),
736
(55%)
women,
580
(44%)
had
secondary
school
highest
level
education,
1089
(82%)
satisfied
589
expressed
deprescribe
1
medications.
varying
levels,
79%
(86
109
patients)
Poland
23%
(21
Bulgaria.
3
most
reported
deprescribed
diuretics
(111
1002
[11%]),
lipid-modifying
agents
(109
acting
on
renin-angiotensin
system
(83
[8%]).
odds
naming
least
lower
higher
(odds
ratio,
0.31;
95%
CI,
0.21-0.47)
0.960;
0.930-0.998).
Conclusions
Relevance
In
this
older,
varied
across
countries,
demonstrating
interventions
could
be
impactful
when
adapted
contexts.
These
findings
highlight
importance
patient-practitioner
communication
ensuring
appropriate
use.
Deprescribing
of
preventive
medication
is
recommended
in
older
patients
with
polypharmacy,
including
people
type
2
diabetes
(T2D).
It
seems
that
many
low-middle-income
countries
are
not
willing
to
have
their
medicines
deprescribed.
This
study
aims
assess
attitudes
Indonesian
T2D
towards
deprescribing
general
and
regarding
specific
cardiometabolic
medicines,
factors
influencing
willingness
stop
medicines.Primary
care
≥60
years
Indonesia
completed
the
revised
Patients'
Attitudes
Towards
(rPATD)
questionnaire.
for
were
reported
descriptively.
Proportions
one
or
more
when
by
different
healthcare
professionals
compared
Chi-square
test.
Multiple
regression
analysis
was
used
analyse
influence
between
patient-related
medicines.The
survey
196
participants
(median
age
69
years,
73%
female).
The
percentages
69,
67,
41%,
practitioner
(GP),
specialist,
pharmacist
initiates
process
(p-value
<
0.001).
Higher
perceived
burden
=
0.03)
less
concerns
about
stopping
0.001)
associated
a
higher
if
proposed
GP.
Patients
using
multiple
glucose-regulating
0.02).
Using
complementary
alternative
stop.
If
pharmacist,
without
substantial
education
than
educated
patients.Only
two-thirds
GP
specialist
this,
even
this.
Attention
should
be
given
especially
among
glucose-lowering
who
may
eligible
but
accept
deprescribing.
Abstract
Background
Psychotropic
polypharmacy
is
common,
increasing,
and
associated
with
higher
risks
of
adverse
effects,
hospitalisations
mortality.
This
study
aimed
to
explore
the
attitudes
beliefs
people
receiving
inpatient
mental
health
care
toward
deprescribing
(
discontinuing
a
medication
when
current
or
potential
risk
outweighs
benefit
)
determine
any
patient
characteristics
these
beliefs.
Methods
A
cross-sectional
survey
patients
admitted
two
open
acute
psychiatric
units
was
conducted
over
6-month
period
in
Australian
metropolitan
city
Adelaide.
Individuals
were
eligible
participate
regardless
their
reason
for
admission,
if
they
at
least
18
years
old
able
converse,
read
write
English,
provide
informed
consent.
Participant
responses
validated
revised
Patients’
Attitudes
Towards
Deprescribing
(rPATD)
questionnaire
collected.
The
rPATD
includes
questions
grouped
into
four
factors:
(i)
perceived
burden
medications,
(ii)
involvement
management,
(iii)
belief
appropriateness
(iv)
concerns
about
stopping,
plus
global
questions.
Participants
encouraged
think
medications
that
use
conditions
completing
questionnaire.
Results
One
hundred
participants
recruited,
mean
age
41.6
(SD
=
13.7).
65%
agreed
would
be
willing
stop
one
more
psychotropic
doctor
said
it
possible.
In
binary
logistic
regression
model,
willingness
have
deprescribed
mostly
strongly
predicted
by
Involvement
factor
score
(odds
ratio
[OR]
5.92,
95%
confidence
interval
[CI]
2.10-15-16.70,
p
<
0.001).
Conclusions
majority
having
deprescribed.
When
medically
justified,
professionals
should
feel
comfortable
initiating
conversations
understand
preferences,
fostering
shared
decision-making
management.
Clinical
trial
number
Not
applicable.
Clinical Interventions in Aging,
Год журнала:
2023,
Номер
Volume 18, С. 1129 - 1143
Опубликована: Июль 1, 2023
Deprescribing
is
essential
for
reducing
inappropriate
medication
use
and
polypharmacy.
For
a
holistic
approach,
it
to
know
how
older
adult
patients
their
caregivers
perceive
deprescribing.To
assess
the
attitude
of
towards
deprescribing
at
Ambo
University
Referral
Hospital.Institutional-based
cross-sectional
study
was
conducted
using
revised
Patients'
Attitude
Towards
tool
(rPATD).
The
data
analyzed
SPSS-25
software.
Backward
linear
regression
logistic
were
used
measure
association
between
outcome
determinant
variables.
two-sided
P-value
≤0.05
with
95%
confidence
interval
utilized
reporting
significant
factors.One
hundred
fifty-six
(81.3%)
respondents
(ie,
85.0%
77.2%
caregivers)
agreed
stop
one
or
more
regular
medications
if
physician
said
possible
despite
98
(51.0%)
them
49.0%
53.3%
being
satisfied
their/their
care
recipient's
medications.
On
overall
aggregate
mean
score,
had
neutral
position
(2.6-3.59)
regarding
burden
concerns
stopping
whereas
majority
disagree
(1.0-2.59)
inappropriateness
they
taking
(3.6-5.0)
need
involvement
in
treatment
decision
making.
Concerns
about
medicine
scores
(AOR
=
0.440,
CI
0.262-0.741,
P
0.035)
perceived
levels
0.653,
0.456-0.936,
0.020)
significantly
associated
willingness
discontinue
satisfaction
regimen
respectively.The
would
like
deprescribe
physicians
recommended
it.
medicines
respectively.
Healthcare
providers
should
prompt
process
by
addressing
Acta Pharmaceutica,
Год журнала:
2024,
Номер
74(2), С. 249 - 267
Опубликована: Май 30, 2024
Abstract
This
umbrella
review
examined
systematic
reviews
of
deprescribing
studies
by
characteristics
intervention,
population,
medicine,
and
setting.
Clinical
humanistic
outcomes,
barriers
facilitators,
tools
for
are
presented.
The
Medline
database
was
used.
search
limited
to
meta-analyses
published
in
English
up
April
2022.
Reviews
reporting
were
included,
while
those
where
depre-scribing
not
planned
supervised
a
healthcare
professional
excluded.
A
total
94
(23
meta--analyses)
included.
Most
explored
clinical
or
outcomes
(70/94,
74
%);
less
attitudes,
(17/94,
18
few
focused
on
(8/94,
8.5
%).
assessing
divided
into
two
groups:
with
intervention
trials
(39/70,
56
%;
16
reviewing
specific
interventions
23
broad
medication
optimisation
interventions),
cessation
(31/70,
44
Deprescribing
feasible
resulted
reduction
inappropriate
medications
.
Complex
shown
reduce
hospitalisation,
falls,
mortality
rates.
In
trials,
higher
frequency
adverse
drug
withdrawal
events
underscores
the
importance
prioritizing
patient
safety
exercising
caution
when
stopping
medicines,
particularly
patients
clear
appropriate
indications.
Healthcare,
Год журнала:
2022,
Номер
10(8), С. 1440 - 1440
Опубликована: Июль 31, 2022
This
study
aims
to
assess
the
prevalence
of
potentially
inappropriate
medications
(PIMs)
and
analyze
relationship
between
PIMs
frailty
among
inpatient
older
adults
aged
65
above
in
Saudi
Arabia.
A
retrospective
cross-sectional
design
was
utilized
during
period
April
2021
2022
all
patients
years
admitted
a
public
tertiary
hospital
Data
on
number
use
were
assessed
using
Beers’
criteria
while
status
“FRAIL
Scale”.
Of
358
patient
files
that
reviewed,
52.2%
males,
60.9%
65−74
years,
82%
married.
The
robust,
prefrail,
frail
5%,
36.9%,
58.1%,
respectively.
According
2019
Beers
criteria,
total
45.8%
(n
=
164)
participants
identified
as
PIMs.
Compared
non-PIMs
group,
group
demonstrated
significant
differences
(p
<
0.001),
comorbidities
0.05),
score
0.001).
strongest
predictor
PIM
comorbidities,
recording
an
odds
ratio
2.86,
(95%
CI
1.21−6.77,
p
0.05).
Our
results
show
significantly
associated
with
multiple
polypharmacy.
clear
assessment
evaluation
tool
may
improve
quality
drug
treatment
adult
population,
particularly
patients.
Abstract
Background
Inappropriate
prescribing
of
medications
and
polypharmacy
among
older
adults
are
associated
with
a
wide
range
adverse
outcomes.
It
is
critical
to
understand
the
attitudes
towards
deprescribing—reducing
use
potentially
inappropriate
(PIMs)—among
this
vulnerable
group.
Such
information
particularly
lacking
in
low
-
middle-income
countries.
Methods
In
study,
we
examined
Chinese
community-dwelling
adults’
deprescribing
as
well
individual-level
correlates.
Through
community-based
health
examination
platform,
performed
cross-sectional
study
by
personally
interviews
using
revised
Patients’
Attitudes
Towards
Deprescribing
(rPATD)
questionnaire
(version
for
adults)
two
communities
located
Suzhou,
China.
We
recruited
participants
who
were
at
least
65
years
had
one
chronic
condition
prescribed
medication.
Results
included
1,897
present
study;
mean
age
was
73.8
(SD
=
6.2
years)
1,023
(53.9%)
women.
Most
disease
(
n
1,364
[71.9%])
took
1–2
regular
drugs
1,483
[78.2%]).
Half
947,
50%)
indicated
that
they
would
be
willing
stop
taking
or
more
their
medicines
if
doctor
said
it
possible,
924
(48.7%)
wanted
cut
down
on
number
taking.
did
not
find
individual
level
characteristics
correlated
deprescribing.
Conclusions
The
proportions
participants’
willingness
much
lower
than
what
prior
investigations
western
populations
reported.
important
identify
factors
influence
develop
patient-centered
practical
guideline
suitable
adults.
Patient Preference and Adherence,
Год журнала:
2024,
Номер
Volume 18, С. 779 - 786
Опубликована: Март 1, 2024
Purpose:
Deprescribing
is
a
complex
process
that
requires
active
patient
involvement,
so
the
patient's
attitude
to
deprescribing
crucial
its
success.This
study
aimed
assess
predictors
of
Saudi
Arabian
patients'
willingness
deprescribe.Patients
and
Methods:
In
this
cross-sectional
study,
adult
patients
from
two
hospitals
in
Riyadh
completed
self-administered
questionnaire
gathering
data
on
demographic
information
Arabic
revised
Patients'
Attitudes
Towards
(rPATD)
questions.Descriptive
analysis
binary
logistic
regression
were
used
analyze
data.Results:
A
total
242
included
(mean
age
59.8
(SD
11.05)
years,
range
25-87
years;
40%
60-69
54.1%
female).The
majority
(90%)
participants
willing
have
medications
deprescribed.Willingness
deprescribe
was
significantly
associated
with
rPATD
involvement
factor
(OR=1.866,
95%
CI
1.177-2.958,p=0.008)
perception
their
health
status
(OR=2.08,CI=1.058-4.119,p=0.034).
Conclusion:The
one
or
more
deprescribed
if
recommended
by
doctors.Patient
perceptions
about
own
important
predictive
factors
could
shape
counseling
education
strategies
encourage
deprescribing.
General
practitioners
(GPs)
have
a
central
role
to
play
on
reduction
of
polypharmacy
and
deprescribing.
This
study
aimed
assess
beliefs
attitudes
towards
deprescribing
in
patients,
aged
65
years
or
older
primary
care,
identify
factors
associated
with
their
willingness
stop
medication.